The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

The Food and Drug Administration (FDA) has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for specific ...

The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...

The companies that make COVID-19 vaccines should update ... would not appear to make a difference in how the FDA approves the next vaccines. The new strategy would continue the current vaccine ...

The majority of Americans may be ineligible for a COVID booster shot this year ... controlled trial data before the FDA approves it for the public. “The FDA’s new framework for vaccine ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines ... and it’s the way the FDA has been approving Covid-19 vaccines for the past few years.

The U.S. Food and Drug Administration is changing the way it approves COVID-19 vaccines ... and it's the way FDA has been approving COVID-19 vaccines for the past few years. For everyone else ...

(CNN) — The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans ... and it’s the way the FDA has been approving Covid-19 vaccines for the past few years.